跳至主要内容
临床试验/CTRI/2022/03/041375
CTRI/2022/03/041375已完成4 期

A Comparative Study to Evaluate the Efficacy and Safety of Chlorthalidone with Losartan versus Amlodipine with Losartan in Patients With Primary Hypertension

BMCRI0 个研究点目标入组 80 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patient willing to give written informed consent
  • 2.Patients who are diagnosed to be having Stage 2 hypertension as per JNC 8 guidelines

排除标准

  • 1.Patients having comorbidities like Chronic kidney disease, Stroke , Congestive Heart Failure, Myocardial infarction , Coronary Artery Disease, Psychiatric Disorders, Suspected Secondary Hypertension (Eg. Renal artery stenosis, Cushingââ?¬•s syndrome )
  • 2.Pregnant and Lactating mothers
  • 3.Patients with hypersensitivity to the study medications

研究者

发起方
BMCRI

相似试验